Pink Sheet is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Condom proposed rule at OMB

This article was originally published in The Tan Sheet

Executive Summary

The Office of Management and Budget July 25 received FDA's proposed rule addressing congressional concerns about condom labeling regarding the effectiveness of the devices. The rule would amend labeling for condoms with and without nonoxynol-9 spermicidal lubricant to clarify the devices' capabilities. The rule also would amend labeling of condoms with N-9 to state that the substance could irritate the vagina, increasing the risk of HIV/AIDS transmission from an infected partner. OMB has 90 days to comment, an FDA spokesman says. FDA will then address OMB's comments before moving to the final rule stage of rulemaking...

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

PS101968

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel